Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fresnel Prism and Lens Co. (FPLC) is a specialized medical device company focused on the manufacturing and distribution of ophthalmic diagnostic and therapeutic products. The company is the primary provider of 3M Press-On Prisms and Lenses, which are widely used by ophthalmologists and optometrists to treat conditions such as strabismus, diplopia, and visual field defects. FPLC's product portfolio includes Bangerter foils for amblyopia treatment, trial lens sets, and various vision testing tools essential for non-surgical binocular vision management. Based in Minnesota, the company serves a global market of eye care professionals and clinical practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fresnel Prism.